# John D. Hainsworth

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-d-hainsworth/

## Facts

| Field | Value |
| --- | --- |
| Citations | 58,031 |
| Field | Lung Cancer Research Studies |
| h-index | 99 |
| i10-index | 410 |
| Last Known Institution | Sarah Cannon |
| OpenAlex ID | https://openalex.org/A5065917441 |
| ORCID iD | https://orcid.org/0000-0002-2848-6546 |
| Works | 789 |

## Researcher papers

- [Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy](https://scholariq.org/papers/increased-survival-with-enzalutamide-in-prostate-cancer-after-chemotherapy/)
- [Abiraterone and Increased Survival in Metastatic Prostate Cancer](https://scholariq.org/papers/abiraterone-and-increased-survival-in-metastatic-prostate-cancer/)
- [Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma](https://scholariq.org/papers/efficacy-and-safety-of-vismodegib-in-advanced-basal-cell-carcinoma/)
- [Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma](https://scholariq.org/papers/clinical-activity-and-molecular-correlates-of-response-to-atezolizumab-alone-or/)
- [Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/everolimus-plus-octreotide-long-acting-repeatable-for-the-treatment-of-advanced/)
- [Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study](https://scholariq.org/papers/early-relapse-of-follicular-lymphoma-after-rituximab-plus-cyclophosphamide/)
- [5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors](https://scholariq.org/papers/5th-national-audit-project-nap5-on-accidental-awareness-during-general/)
- [Phase II Study of Liposomal Doxorubicin in Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer](https://scholariq.org/papers/phase-ii-study-of-liposomal-doxorubicin-in-platinum-and-paclitaxel-refractory/)

## Researcher topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer Diagnosis and Treatment](https://scholariq.org/topics/cancer-diagnosis-and-treatment/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Researcher university

- [Sarah Cannon](https://scholariq.org/institutions/sarah-cannon/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.